We are happy to announce that Omixon is exhibiting at the 39th annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI), 17-21 November, Chicago (Sheraton Chicago Hotel and Towers). ASHI is dedicated to advance the science and application of histocompatibility and immunogenetics; providing a forum for the exchange of information; and advocating the highest standards of laboratory testing in the interest of optimal patient care.

Meet our colleagues at booth No. 313, Attila Berces, Founder and Chairman, Tim Hague, CEO and Craig Funnell, Director of Sales & Marketing of Omixon.